Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection

Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection

Abstract Background As an alternative biomarker of intrahepatic covalently closed circular DNA (cccDNA) transcriptional activity, hepatitis B virus (HBV) RNA may evolve during long-lasting virus-host interactions during chronic hepatitis B viral infection. The distribution pattern of serum HBV RNA l...

Full description

Bibliographic Details
Main Authors:	Yayun Liu, Meng Jiang, Jianya Xue, Hongli Yan, Xuesong Liang
Format:	Article
Language:	English
Published:	BMC 2019-04-01
Series:	BMC Gastroenterology
Subjects:	Hepatitis B virus (HBV) Pregenomic RNA (pgRNA) Natural history Hepatitis B e antigen (HBeAg) Hepatitis B surface antigen (HBsAg)
Online Access:	http://link.springer.com/article/10.1186/s12876-019-0966-4

Similar Items

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
by: Guangjun Song, et al.
Published: (2023-11-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

HBV Hepatitis and Related Renal Nephropathies: Pathogenesis and Treatment
by: Maurizio Salvadori, et al.
Published: (2020-11-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
by: Yael Gozlan, et al.
Published: (2022-03-01)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
by: Abhishek Aggarwal, et al.
Published: (2023-04-01)

The Progress of Anti-HBV Constituents from Medicinal Plants in China
by: Chang-An Geng, et al.
Published: (2018-07-01)

Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan
by: Aqib Nazeer, et al.
Published: (2019-12-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
by: Xiaomei Wang, et al.
Published: (2020-10-01)

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
by: Qingrong Zhang, et al.
Published: (2023-02-01)

Status of Hepatitis Be Antigen in Chronic Hepatitis B Patients from Various Regions of Pakistan
by: Agha Babar Hussain
Published: (2017-09-01)

Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
by: Jianfei Long, et al.
Published: (2023-09-01)

Corrigendum: Difference of gut microbiota between patients with negative and positive HBeAg in chronic hepatitis B and the effect of tenofovir alafenamide on intestinal flora
by: Jianfei Long, et al.
Published: (2023-11-01)

Hepatitis B Virus (HBV) a Severe Health Problem in Mardan, Khyber Pakhtunkhwa
by: Muhammad Waqar, et al.
Published: (2019-02-01)

Frequency of HBsAg in pregnant women in Gorgan, Iran
by: Cheraghali F (MD), et al.
Published: (2012-01-01)

Naturally Occurring Mutations within HBV Surface Promoter II Sequences Affect Transcription Activity, HBsAg and HBV DNA Levels in HBeAg-Positive Chronic Hepatitis B Patients
by: Ran Hao, et al.
Published: (2019-01-01)

Compositional changes of PBL population in patients with chronic hepatitis B virus infection
by: Khabiri Alireza, et al.

Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study
by: Fumitaka Suzuki, et al.
Published: (2021-12-01)

HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
by: Ferruccio Bonino, et al.
Published: (2022-07-01)

Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy
by: Chenyu Xu, et al.
Published: (2018-07-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

Response of Preterm Infants of Mothers Who Are Chronic Carriers of Both HBsAg and HBeAg to Pre-52 Containing Hepatitis 8 Vaccine (TGP 943) - A Preliminary Report
by: Abdul Hamid Sutohardjo
Published: (2018-10-01)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation
by: Yifei Guo, et al.
Published: (2023-02-01)

[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis]
by: Roberto Patriarchi, et al.
Published: (2015-12-01)

Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
by: Alicia Vachon, et al.
Published: (2021-05-01)

Hepatitis B virus exposure in human immunodeficiency virus seropositive Cuban patients
by: Licel Rodríguez, et al.
Published: (2000-04-01)

Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment
by: Goh Eun Chung, et al.
Published: (2022-07-01)

Commentary: Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Maria Pfefferkorn, et al.
Published: (2022-12-01)

Seroprevalence of hepatitis B surface antigen and its correlation with risk factors among new recruits in Turkey
by: Tulin Altay, et al.

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
by: Luisa Roade, et al.
Published: (2023-10-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
by: Gian Paolo Caviglia, et al.
Published: (2021-01-01)

Low positivity rates for HBeAg and HBV DNA in rheumatoid arthritis patients: a case–control study
by: Yue Jia, et al.
Published: (2022-06-01)

A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
by: Ning Wang, et al.
Published: (2022-09-01)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
by: Chih-Wei Tseng, et al.
Published: (2022-04-01)

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
by: Jian Wang, et al.
Published: (2024-12-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
by: Cheng-Yuan Peng, et al.
Published: (2015-04-01)

Comparison of evolutionary patterns of different HBeAg status in HBV genotype B and C
by: Cai Ying, et al.
Published: (2015-12-01)

A comparison on HBsAg and HBsAb prevalence in patients with Down syndrome and other mentally retarded patients living in retarded children institutes in Tehran
by: Sahebjamei M. Associate Professor, et al.
Published: (2003-06-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
by: Taqwa Hashim, et al.
Published: (2023-12-01)